Related Experiment Video
Updated: Jul 17, 2026
05:46
Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue
Published on: June 9, 2020
Nanomolecular histopathology for renal tumor classification
Andrew Young1, Mahul Amin, John Petros
1Emory University and the Atlanta VA Medical Center, Decatur, GA 30033 USA (phone: 404-321-6111 ext 3441; fax: 404-235-3007;
Summary
Novel nanoparticle-based assays offer a sensitive and quantitative method for classifying renal tumors by integrating histopathology with nanomolecular profiling. This approach overcomes limitations of current techniques for precise tumor subtyping.
Area of Science:
- Oncology
- Nanotechnology
- Biochemistry
Background:
- Renal tumor classification relies on histopathology, which can be challenging due to heterogeneous morphology.
- Existing molecular assays like RT-PCR and gene microarrays lack morphologic correlation or multiplexing capabilities.
- Immunohistochemistry (IHC) bridges molecular data and morphology but is difficult to quantify or multiplex.
Purpose of the Study:
- To develop a novel assay integrating histopathology with nanomolecular expression profiling for sensitive and specific renal tumor classification.
- To overcome the limitations of current diagnostic methods for renal tumors.
Main Methods:
- Development of novel IHC assays utilizing antibodies conjugated to nanoparticle tags.
- Nanoparticle tags possess surface-enhanced Raman scattering (SERS) properties for detection.
- Utilizing standard microscopic equipment for SERS-IHC analysis on fixed tissues.
Main Results:
- Preliminary data indicates SERS-IHC is feasible with standard microscopy.
- The SERS-IHC method shows potential for sensitive and quantitative multiplex assays.
- Successful application on fixed tissues for renal tumor analysis.
Conclusions:
- Direct integration of histopathology with nanomolecular profiling via SERS-IHC is a promising approach for renal tumor classification.
- This novel technique offers a sensitive, quantitative, and multiplexable solution for improved tumor subtyping.
- SERS-IHC has the potential to enhance diagnostic accuracy and clinical management of renal tumors.
